The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | Single-cell multiomics analysis and the role of PHF19 expression in high-risk multiple myeloma
Travis Johnson, PhD, MS, Indiana University School of Medicine, Indianapolis, IN, shares some insights into a single-cell multiomics study which investigated the mechanisms behind high-risk myeloma, drawing focus on the role of PHF19 expression. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
